 Vericel is a high growth, disruptive biotechnology company with annual sales increasing at a 30 rate prior to the COVID-19 pandemic. The Companys tissue repair and restoration products are proprietary and backed by medical research showing greater effectiveness than traditional competing solutions and approaches. 